Literature DB >> 36266446

New insights into the epitranscriptomic control of pluripotent stem cell fate.

Young Hyun Che1, Hojae Lee2, Yong Jun Kim3,4,5.   

Abstract

Each cell in the human body has a distinguishable fate. Pluripotent stem cells are challenged with a myriad of lineage differentiation options. Defects are more likely to be fatal to stem cells than to somatic cells due to the broad impact of the former on early development. Hence, a detailed understanding of the mechanisms that determine the fate of stem cells is needed. The mechanisms by which human pluripotent stem cells, although not fully equipped with complex chromatin structures or epigenetic regulatory mechanisms, accurately control gene expression and are important to the stem cell field. In this review, we examine the events driving pluripotent stem cell fate and the underlying changes in gene expression during early development. In addition, we highlight the role played by the epitranscriptome in the regulation of gene expression that is necessary for each fate-related event.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36266446     DOI: 10.1038/s12276-022-00824-x

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   12.153


  175 in total

Review 1.  Stem cells: a new lease on life.

Authors:  E Fuchs; J A Segre
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor.

Authors:  Yong Jun Kim; Hotae Lim; Zhe Li; Yohan Oh; Irina Kovlyagina; In Young Choi; Xinzhong Dong; Gabsang Lee
Journal:  Cell Stem Cell       Date:  2014-08-21       Impact factor: 24.633

3.  Opening stem cell research and development: a policy proposal for the management of data, intellectual property, and ethics.

Authors:  David E Winickoff; Krishanu Saha; Gregory D Graff
Journal:  Yale J Health Policy Law Ethics       Date:  2009

Review 4.  The role of cell lineage in development.

Authors:  G S Stent
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1985-12-17       Impact factor: 6.237

Review 5.  Embryonic stem cells: prospects for developmental biology and cell therapy.

Authors:  Anna M Wobus; Kenneth R Boheler
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

6.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

Review 7.  Totipotency, pluripotency and nuclear reprogramming.

Authors:  Shoukhrat Mitalipov; Don Wolf
Journal:  Adv Biochem Eng Biotechnol       Date:  2009       Impact factor: 2.635

Review 8.  Direct Conversion to Achieve Glial Cell Fates: Oligodendrocytes and Schwann Cells.

Authors:  Wonjin Yun; Yong Jun Kim; Gabsang Lee
Journal:  Int J Stem Cells       Date:  2022-02-28       Impact factor: 2.500

9.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

10.  Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression.

Authors:  Gabsang Lee; Christina N Ramirez; Hyesoo Kim; Nadja Zeltner; Becky Liu; Constantin Radu; Bhavneet Bhinder; Yong Jun Kim; In Young Choi; Bipasha Mukherjee-Clavin; Hakim Djaballah; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2012-11-25       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.